Variant report
Variant | nsv524168 |
---|---|
Chromosome Location | chr2:35409131-35416075 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CRIM1-1 | chr2:35410303-35410755 | ENSG00000226994.3 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561424126 | chr2:35409605-35409606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530470270 | chr2:35409627-35409628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1561554 | chr2:35409697-35409698 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs570264633 | chr2:35409705-35409706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532731285 | chr2:35409724-35409725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552725901 | chr2:35409747-35409748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369984398 | chr2:35409748-35409749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115692302 | chr2:35409766-35409767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535027090 | chr2:35409770-35409771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554905457 | chr2:35409821-35409822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186686398 | chr2:35409829-35409830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372978086 | chr2:35409864-35409865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537394361 | chr2:35409965-35409966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556962082 | chr2:35410064-35410065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12465444 | chr2:35410101-35410102 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs74467769 | chr2:35410184-35410185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377632213 | chr2:35410245-35410246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116198442 | chr2:35410263-35410264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572554166 | chr2:35410334-35410335 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs149805471 | chr2:35410336-35410337 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs371113788 | chr2:35410367-35410368 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs561763070 | chr2:35410368-35410369 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs191993549 | chr2:35410387-35410388 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs77196781 | chr2:35410459-35410460 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs7605842 | chr2:35410478-35410479 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs377193325 | chr2:35410479-35410480 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs75102113 | chr2:35410492-35410493 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs182857263 | chr2:35410493-35410494 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs79210238 | chr2:35410535-35410536 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs548401991 | chr2:35410548-35410549 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs528646181 | chr2:35410575-35410576 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs548386107 | chr2:35410583-35410584 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs568479503 | chr2:35410605-35410606 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs75275173 | chr2:35410625-35410626 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs542150510 | chr2:35410643-35410644 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs563318261 | chr2:35410681-35410682 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs557233951 | chr2:35410683-35410684 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs530706279 | chr2:35410694-35410695 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs570369699 | chr2:35410695-35410696 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs539249265 | chr2:35410733-35410734 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs375328387 | chr2:35410739-35410740 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs373615688 | chr2:35410762-35410763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140551250 | chr2:35410765-35410766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545516896 | chr2:35410780-35410781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572690821 | chr2:35410788-35410789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541941549 | chr2:35410790-35410791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555147824 | chr2:35410803-35410804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4670445 | chr2:35410810-35410811 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs76261309 | chr2:35410817-35410818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564020105 | chr2:35410833-35410834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:35409600-35409800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:35409800-35411000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:35411000-35411600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |